Fredun Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹690Day's Price Range₹719.9552 Week's Low
52 Week's High
₹63552-Week Price Range₹1,054
| Returns % | |
| 1 Month Return | -2.62 % |
| 3 Month Return | -1.75 % |
| 1 Year Return | -16.23 % |
| Market Stats | |
| Previous Close | ₹717.65 |
| Open | ₹717.65 |
| Volume | 3,257.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹337.24Cr |
Fredun Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹337.24 Cr |
| P/B Ratio | 2.81 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 14.34 |
Fredun Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹337.24 Cr | 49.96% | 0.74 | NA | NA | |
| NA | ₹271.68 Cr | 110.1% | 0.52 | ₹16 Cr | ₹108 Cr | |
| NA | ₹2,152.42 Cr | 5.69% | 0.52 | NA | NA | |
| NA | ₹142.69 Cr | 3.78% | 0.59 | NA | NA | |
| NA | ₹93.75 Cr | 10.89% | 0.54 | NA | NA |
About Fredun Pharmaceuticals Ltd
Consequently, FPL was approved to be listed on the stock exchange in April 1996, and decided to use the funding for international expansion, repaying term loans, and reducing interest burden. Furthermore, FPL is continually registering its products across various countries with the hopes of increasing its overall turnover and boosting export orders. Currently, FPL is successfully registering drugs in countries such as Nepal, Tanzania, Uganda, and Sri Lanka.
Share Price: ₹704.90 per share as on 21 Jan, 2025 04:01 PM
Market Capitalisation: ₹337.24Cr as of today
Chairperson Name: Daulat N Medhora
| Organisation | Fredun Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Stock Rises on New Plant Announcement - 27 Nov, 2024
Fredun Pharmaceuticals Limited's stock surged 3% after announcing the launch of a new functional foods manufacturing facility in Palghar, Maharashtra. Set to begin operations by Q3 FY26, the plant aims to produce high-quality functional foods for pets, addressing the growing demand for proper pet nutrition in India.
Insights on Fredun Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 49.24% to 49.48% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 68.0%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 128.8%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 49.17% to 48.93% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, Fredun Pharma stock has moved down by -26.5%
Fredun Pharmaceuticals Ltd Financials
Fredun Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 48.93% | ||
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.48% | 0.49 | |
| Others | 1.59% |
Fredun Pharmaceuticals Ltd Key Indicators
Fredun Pharmaceuticals Ltd Earnings and Dividends
Fredun Pharmaceuticals Ltd Earnings Results
Fredun Pharmaceuticals Ltd’s net profit jumped 8.38% since last year same period to ₹4.27Cr in the Q2 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 3.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsFredun Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 - translating a dividend yield of 0.20%.
Read More about Dividends
Fredun Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Fredun Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd share price today stands at ₹704.9, Open. ₹717.65 ; Previous Close. ₹717.65 ; High. ₹719.95 ; Low. ₹690 ; 52 Week High. ₹1054 ; 52 Week Low: ₹635.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Fredun Pharmaceuticals Ltd shares.
Fredun Pharmaceuticals Ltd is not listed on NSE
Fredun Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Fredun Pharmaceuticals Ltd is ₹719.95.
- Today’s lowest price of Fredun Pharmaceuticals Ltd is ₹690.
Today’s traded volume of Fredun Pharmaceuticals Ltd(539730) is 3,257.00.
Today’s market capitalisation of Fredun Pharmaceuticals Ltd(539730) is ₹337.24Cr.
| Fredun Pharmaceuticals Ltd(539730 | Price |
|---|---|
52 Week High | ₹1054 |
52 Week Low | ₹635 |
Fredun Pharmaceuticals Ltd(539730) share price is ₹704.9. It is down -33.12% from its 52 Week High price of ₹1054
Fredun Pharmaceuticals Ltd(539730) share price is ₹704.9. It is up 11.01% from its 52 Week Low price of ₹635
| Fredun Pharmaceuticals Ltd(539730 | Returns |
|---|---|
1 Day Returns | -12.75% |
1 Month Returns | -2.62% |
3 Month Returns | -1.75% |
1 Year Returns | -16.23% |